Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- In Phase 1, to evaluate the dose response of aliskiren in msSBP change at end of Phase 1 from the baseline, as measured by office blood pressure reading, in children 6 to 17 years old with hypertension. - In Phase 2 (placebo controlled phase), to evaluate pooled treatment effect of aliskiren in msSBP change at end of Phase 2 from the end of Phase 1, compared to placebo pooled from corresponding arms, as measured by office blood pressure reading, in children 6 to 17 years old with hypertension.
Critère d'inclusion
- Hypertension